• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Theophylline toxicity--a consequence of congestive heart failure.

作者信息

LeGatt D F

出版信息

Drug Intell Clin Pharm. 1983 Jan;17(1):59-60. doi: 10.1177/106002808301700119.

DOI:10.1177/106002808301700119
PMID:6825561
Abstract

A case is reported of an elderly patient with congestive heart failure (CHF), who was treated with juvenile oral doses of theophylline (Theo-Dur). The patient experienced toxic symptoms, and plasma concentrations were determined. A value of 60.6 micrograms/ml was reported and the theophylline administration was subsequently discontinued. Plasma concentrations and toxicity of theophylline are unpredictable in patients with CHF because of the great variability in clearance. This case demonstrates the necessity for careful monitoring of theophylline plasma levels in CHF patients.

摘要

相似文献

1
Theophylline toxicity--a consequence of congestive heart failure.
Drug Intell Clin Pharm. 1983 Jan;17(1):59-60. doi: 10.1177/106002808301700119.
2
Theophylline clearance in obese patients in relation to smoking and congestive heart failure.肥胖患者中茶碱清除率与吸烟及充血性心力衰竭的关系。
Drug Intell Clin Pharm. 1983 Apr;17(4):274-6. doi: 10.1177/106002808301700406.
3
Theophylline clearance: effect of marked obesity.茶碱清除率:显著肥胖的影响。
Clin Pharmacol Ther. 1980 Nov;28(5):619-23. doi: 10.1038/clpt.1980.212.
4
Theophylline disposition in acutely ill hospitalized patients. The effect of smoking, heart failure, severe airway obstruction, and pneumonia.急性病住院患者的茶碱处置。吸烟、心力衰竭、严重气道阻塞及肺炎的影响。
Am Rev Respir Dis. 1978 Aug;118(2):229-38. doi: 10.1164/arrd.1978.118.2.229.
5
Pharmacokinetic comparison of a once-daily and twice-daily theophylline delivery system.每日一次和每日两次茶碱给药系统的药代动力学比较。
Clin Ther. 1994 Jul-Aug;16(4):686-92.
6
Changes in theophylline clearance during acute illness.急性疾病期间茶碱清除率的变化。
JAMA. 1978 Oct 20;240(17):1882-4.
7
Theophylline absorption from sustained-release products: comparative steady-state bioavailability of once-daily Theo-Dur, Theo-24, and Uniphyl.茶碱从缓释制剂中的吸收:每日一次服用Theo-Dur、Theo-24和优喘平的比较稳态生物利用度。
J Clin Pharmacol. 1987 Nov;27(11):855-61. doi: 10.1002/j.1552-4604.1987.tb05579.x.
8
Case Report: The risks associated with chronic theophylline therapy and measures designed to improve monitoring and management.病例报告:与慢性茶碱治疗相关的风险以及旨在改善监测与管理的措施。
BMC Pharmacol Toxicol. 2016 Mar 5;17:13. doi: 10.1186/s40360-016-0050-4.
9
Conversion from intravenous to oral dosing using sustained-release theophylline tablets.
Drug Intell Clin Pharm. 1982 Oct;16(10):772-4. doi: 10.1177/106002808201601013.
10
A comparison of the plasma profiles of two slow-release theophylline preparations (Nuelin depot and Theo-dur) in healthy volunteers.两种缓释茶碱制剂(Nuelin长效型和茶喘平)在健康志愿者体内的血浆浓度曲线比较。
Ann Allergy. 1981 May;46(5):279-80.

引用本文的文献

1
Case Report: The risks associated with chronic theophylline therapy and measures designed to improve monitoring and management.病例报告:与慢性茶碱治疗相关的风险以及旨在改善监测与管理的措施。
BMC Pharmacol Toxicol. 2016 Mar 5;17:13. doi: 10.1186/s40360-016-0050-4.